Literature DB >> 19138235

Managing oral anticoagulation therapy: improving clinical outcomes. A review.

F Ryan1, S Byrne, S O'Shea.   

Abstract

Many physicians are reluctant to prescribe oral anticoagulation therapy (OAT) because of the fear of haemorrhagic complications. Changes in patient health, lifestyle or diet and other drugs can alter the effectiveness of oral anticoagulants. These potential interferences, added to the fact that each individual has a different reaction to these drugs, requires that therapy is monitored regularly. This article aims to review those strategies which help to achieve optimal anticoagulation control and improve the outcomes of OAT. Relevant articles were identified through a search of MEDLINE and included publications reporting on intensity of anticoagulation, the initiation of therapy and the role of pharmacogenetics, the transition from primary to secondary care, management by specialized clinics using decision support software and home-testing. Implementation of these strategies would increase the use of oral anticoagulants by physicians and offers the potential to improve patient safety and reduce adverse events.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19138235     DOI: 10.1111/j.1365-2710.2008.00959.x

Source DB:  PubMed          Journal:  J Clin Pharm Ther        ISSN: 0269-4727            Impact factor:   2.512


  7 in total

1.  Impact of clinical pharmacist intervention in anticoagulation clinic in Sudan.

Authors:  Nahid Osman Ahmed; Bashier Osman; Yassein Mohamed Abdelhai; Tariq Muhammed Hashim El-Hadiyah
Journal:  Int J Clin Pharm       Date:  2017-05-15

2.  Does satisfaction with information equate to better anticoagulant control?

Authors:  Laura Sahm; Lisa Quinn; Michael Madden; Helen L Richards
Journal:  Int J Clin Pharm       Date:  2011-03-26

3.  Utility of a dedicated pediatric cardiac anticoagulation program: the Boston Children's Hospital experience.

Authors:  Jenna M Murray; Amy Hellinger; Roger Dionne; Loren Brown; Rosemary Galvin; Suzanne Griggs; Karen Mittler; Kathy Harney; Shannon Manzi; Christina VanderPluym; Annette Baker; Patricia O'Brien; Cheryl O'Connell; Christopher S Almond
Journal:  Pediatr Cardiol       Date:  2015-01-09       Impact factor: 1.655

4.  Cost-Utility and Budget Impact Analysis of Implementing Anticoagulation Clinics and Point-of-Care Monitoring Devices in Anticoagulated Patients in Argentina.

Authors:  Osvaldo Ulises Garay; Gonzalo Guiñazú; Yolanda Patricia Adamczuk; Cristina Duboscq
Journal:  Pharmacoecon Open       Date:  2022-07-14

5.  Enoxaparin versus Unfractionated Heparin for the Perioperative Anticoagulant Therapy in Patients with Mechanical Prosthetic Heart Valve Undergoing Non-Cardiac Surgery.

Authors:  Luminita Iliuta; Andreea Andronesi; Georgiana Camburu; Marius Rac-Albu
Journal:  Medicina (Kaunas)       Date:  2022-08-18       Impact factor: 2.948

6.  Point-of-Care International Normalized Ratio (INR) Monitoring Devices for Patients on Long-term Oral Anticoagulation Therapy: An Evidence-Based Analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2009-09-01

Review 7.  Physician's fear of anticoagulant therapy in nonvalvular atrial fibrillation.

Authors:  Souvik Sen; Katherine Willett Dahlberg
Journal:  Am J Med Sci       Date:  2014-12       Impact factor: 2.378

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.